P. Soulard

发表

Structure-based maximal affinity model predicts small-molecule druggability

Daniel R. Caffrey, Anna C. Salzberg, A. Cheng, 2007, Nature Biotechnology.

Distinct neuroprotective profiles for σ ligands against N-methyl-d-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies

P. Soulard, A. Privat, J. Junien, 1995, Brain Research.

Effects of a new σ ligand, JO 1784, on cysteamine ulcers and duodenal alkaline secretion in rats

P. Soulard, C. Rozé, J. Junien, 1993 .

Effects of a New 0 Ligand, JO 1784, on Duodenal Alkaline Secretion in Rats Cysteamine Ulcers and

P. Soulard, C. Rozé, J. Junien, 1993 .

Phosphodiesterase 4 inhibitors reduce human dendritic cell inflammatory cytokine production and Th1-polarizing capacity.

P. Soulard, A. Thierry, C. Moulon, 2003, International immunology.

Modulation of human dendritic cell function by therapeutic agents

P. Soulard, A. Thierry, C. Moulon, 2007 .

Spiroquinazolinones as novel, potent, and selective PDE7 inhibitors. Part 1.

P. Soulard, P. Berna, B. Bertin, 2004, Bioorganic & medicinal chemistry letters.

Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 1: design, synthesis and structure-activity relationship studies.

P. Soulard, P. Berna, B. Bertin, 2004, Bioorganic & medicinal chemistry letters.

Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.

Brendan Connolly, P. Soulard, M. Mclaughlin, 2008, Analytica chimica acta.

Abstract 2269: ATR inhibitor M6620 enhances anti-tumor efficacy of the combination of the anti-PD-L1 antibody avelumab with platinum-based chemotherapy

P. Soulard, A. Blaukat, A. Zimmermann, 2019, Immunology.

Modulation of human dendritic cell function by therapeutic agents

P. Soulard, A. Thierry, C. Moulon, 2002 .